Filing Flows › Retractable Technologies (RVP) › Syringes revenue
Retractable Technologies (RVP) Syringes revenue by quarter
Retractable Technologies' Syringes revenue was $6.3M in Q2 2026 (second quarter 2026), +8% from Q1 2026. Over the last 7 quarters it ranged from $5.7M (Q4 2024) to $7.0M (Q1 2025).
| Quarter | Syringes revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $6.3M | +8% | +5% |
| Q1 2026 | $5.8M | -6% | -17% |
| Q4 2025 | $6.2M | +6% | +9% |
| Q3 2025 | $5.8M | -1% | — |
| Q2 2025 | $5.9M | -15% | — |
| Q1 2025 | $7.0M | +22% | — |
| Q4 2024 | $5.7M | — | — |
Q2 2026 at a glance
Retractable Technologies, Q2 2026: revenue $7.2M (-31% year over year), operating margin -71.5%, net earnings $2.8M, operating cash flow −$1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Retractable Technologies' Syringes revenue?
Retractable Technologies' Syringes revenue was $6.3M in Q2 2026 (second quarter 2026), +8% from Q1 2026.
How has Retractable Technologies' Syringes revenue changed?
Over the last 7 quarters it ranged from $5.7M (Q4 2024) to $7.0M (Q1 2025).
Q2 2026 results → · How Retractable Technologies makes money →